The neuroimaging industry is dynamic, constantly looking for novel approaches to identify and cure complex neurological disorders. Emerging magnetic resonance imaging (MRI) and computed tomography (CT) technologies have helped address the challenges in neuroimaging, such as limited spatiotemporal resolution, cost and accessibility, and patient safety.
• How do emerging technologies such as magnetic resonance fingerprinting (MRF), magnetic particle imaging (MPI), and positron emission tomography-MR imaging (PET-MRI) contribute to personalized medicine and precision neurology in the next five years?
• What growth opportunities exist in early-stage MRI and CT with the expanding applications of Neuroimaging-as-a-Service (NaaS) in neuromarketing and sleep deprivation management?
• What are the potential benefits and outcomes of partnerships between top-tier neuroimaging companies and predictive AI startups in the emerging technologies of MRI and CT?
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured open discussion with our growth experts providing unparalleled industry intelligence, technology advancements, and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.